Medtronic releases positive heart failure device data
This article was originally published in Clinica
Executive Summary
Medtronic's investigational heart failure (HF) device is an effective treatment for patients with the condition who are also at risk of dangerous ventricular arrhythmias, according to trial data revealed at last month's American College of Cardiology (ACC) meeting in Atlanta.